George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLWB.L Regulatory News (LWB)

  • There is currently no data for LWB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Low and Bonar plc

1 Nov 2019 15:22

Aberforth Partners LLP - Form 8.3 - Low and Bonar plc

Aberforth Partners LLP - Form 8.3 - Low and Bonar plc

PR Newswire

London, November 1

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON

WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Aberforth Partners LLP, on behalf of discretionary clients.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Low & Bonar plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 31/10/2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”YES / NO / N/A NO If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary Shares
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled: 118,838,362 17.23% 0 0.0
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL: 118,838,362 17.23% 0 0.0

Aberforth Partners LLP does not have discretion regarding voting decisions in respect of 47,042,758 shares included in the total disclosed above. This total includes 40,672,737 shares held by The Wellcome Trust, who retain voting control over their shareholding. No other client, who falls into this category, holds more than 1% of the relevant security.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:N/A
Details, including nature of the rights concerned and relevant percentages:N/A

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
Ordinary Shares Sale 140,000  14.45p

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/A

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure: 01 November 2019
Contact name:Michael Campbell, for Aberforth Partners LLP
Telephone number:0131 220 0733

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
25th Jul 20197:00 amRNSDisposal of Needle-Punched Non-Wovens business
11th Jul 201912:07 pmRNSSecond Price Monitoring Extn
11th Jul 201912:02 pmRNSPrice Monitoring Extension
10th Jul 20197:00 amRNSAppointment of non-executive director
9th Jul 20194:35 pmRNSPrice Monitoring Extension
2nd Jul 20197:00 amRNSCompletion of sale of Construction Fibres business
28th Jun 201910:00 amRNSTotal Voting Rights
25th Jun 20197:00 amRNSNotice of interim results and update on trading
13th Jun 20194:40 pmRNSSecond Price Monitoring Extn
13th Jun 20194:35 pmRNSPrice Monitoring Extension
13th Jun 201912:07 pmRNSSecond Price Monitoring Extn
13th Jun 201912:02 pmRNSPrice Monitoring Extension
12th Jun 201912:08 pmRNSSecond Price Monitoring Extn
12th Jun 201912:02 pmRNSPrice Monitoring Extension
11th Jun 201912:02 pmRNSPrice Monitoring Extension
4th Jun 201912:07 pmRNSSecond Price Monitoring Extn
4th Jun 201912:02 pmRNSPrice Monitoring Extension
3rd Jun 20197:30 amRNSDisposal of Construction Fibres business
31st May 201912:45 pmRNSTotal Voting Rights
30th May 20194:40 pmRNSSecond Price Monitoring Extn
30th May 20194:35 pmRNSPrice Monitoring Extension
29th May 20194:40 pmRNSSecond Price Monitoring Extn
29th May 20194:35 pmRNSPrice Monitoring Extension
28th May 201910:44 amRNSHolding(s) in Company
20th May 20197:01 amRNSChange of Leadership
20th May 20197:00 amRNSTrading Update
2nd May 20194:40 pmRNSSecond Price Monitoring Extn
2nd May 20194:35 pmRNSPrice Monitoring Extension
1st May 20198:00 amRNSTotal Voting Rights
15th Apr 201912:07 pmRNSSecond Price Monitoring Extn
15th Apr 201912:02 pmRNSPrice Monitoring Extension
12th Apr 201912:07 pmRNSSecond Price Monitoring Extn
12th Apr 201912:02 pmRNSPrice Monitoring Extension
10th Apr 20194:46 pmRNSDirector/PDMR Shareholding
5th Apr 20194:00 pmRNSDirector/PDMR Shareholding
5th Apr 20193:55 pmRNSResult of AGM
3rd Apr 20194:40 pmRNSSecond Price Monitoring Extn
3rd Apr 20194:35 pmRNSPrice Monitoring Extension
1st Apr 201910:22 amRNSDirector Declaration
1st Apr 20199:00 amRNSTotal Voting Rights
1st Apr 20197:00 amRNSTrading Update
1st Mar 201910:00 amRNSAnnual Financial Report
28th Feb 20193:46 pmRNSTotal Voting Rights
21st Feb 201912:39 pmRNSHolding(s) in Company
21st Feb 20197:00 amRNSAppointment of Joint Broker
20th Feb 20193:54 pmRNSHolding(s) in Company
20th Feb 20197:02 amRNSTotal Voting Rights
20th Feb 20197:01 amRNSDirector/PDMR Shareholding
20th Feb 20197:00 amRNSAdmission of New Shares
19th Feb 20191:03 pmRNSResults of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.